Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2014Lara D. VeekenOpen Access

Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus

View Full Paper
Ask AI
Bookmark
Share

Authors

TLTingting LiCenter for Disease ControlSPStephenie D. ProkopecOntario Institute for Cancer ResearchSMS. MorrisonUniversity of Otago

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Li et al. (2014) studied this question.

synapsesocial.com/papers/6a828a110de57fd8eeb2812chttps://doi.org/10.1093/rheumatology/keu326
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.1993 · 637 citations
  2. 2The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity2004 · 138 citations
  3. 3Measurement of increases in anti‐double‐stranded dna antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus1990 · 578 citations
  4. 4Dynamics and equilibria of nucleosomes at elevated ionic strength.1984 · 96 citations
  5. 5Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients2012 · 64 citations